Toronto Dominion Bank’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-5
| Closed | -$13 | – | 1249 |
|
|
2024
Q2 | $13 | Hold |
5
| – | – | ﹤0.01% | 1215 |
|
|
2024
Q1 | $25 | Hold |
5
| – | – | ﹤0.01% | 1205 |
|
|
2023
Q4 | $44 | Hold |
5
| – | – | ﹤0.01% | 1283 |
|
|
2023
Q3 | $57 | Hold |
5
| – | – | ﹤0.01% | 1506 |
|
|
2023
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 1619 |
|
|
2023
Q1 | $0 | Buy |
+5
| New | – | ﹤0.01% | 1460 |
|
|
2022
Q3 | – | Sell |
-65
| Closed | -$1K | – | 1468 |
|
|
2022
Q2 | $1K | Buy |
+65
| New | +$1K | ﹤0.01% | 1262 |
|